These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29350351)

  • 1. Convection-enhanced delivery of cetuximab conjugated iron-oxide nanoparticles for treatment of spontaneous canine intracranial gliomas.
    Freeman AC; Platt SR; Holmes S; Kent M; Robinson K; Howerth E; Eagleson J; Bouras A; Kaluzova M; Hadjipanayis CG
    J Neurooncol; 2018 May; 137(3):653-663. PubMed ID: 29350351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convection-Enhanced Delivery of Polymeric Nanoparticles Encapsulating Chemotherapy in Canines with Spontaneous Supratentorial Tumors.
    Young JS; Bernal G; Polster SP; Nunez L; Larsen GF; Mansour N; Podell M; Yamini B
    World Neurosurg; 2018 Sep; 117():e698-e704. PubMed ID: 29960096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles.
    Kaluzova M; Bouras A; Machaidze R; Hadjipanayis CG
    Oncotarget; 2015 Apr; 6(11):8788-806. PubMed ID: 25871395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles.
    Bouras A; Kaluzova M; Hadjipanayis CG
    J Neurooncol; 2015 Aug; 124(1):13-22. PubMed ID: 25981803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and feasibility of the NanoKnife system for irreversible electroporation ablative treatment of canine spontaneous intracranial gliomas.
    Rossmeisl JH; Garcia PA; Pancotto TE; Robertson JL; Henao-Guerrero N; Neal RE; Ellis TL; Davalos RV
    J Neurosurg; 2015 Oct; 123(4):1008-25. PubMed ID: 26140483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canine spontaneous glioma: a translational model system for convection-enhanced delivery.
    Dickinson PJ; LeCouteur RA; Higgins RJ; Bringas JR; Larson RF; Yamashita Y; Krauze MT; Forsayeth J; Noble CO; Drummond DC; Kirpotin DB; Park JW; Berger MS; Bankiewicz KS
    Neuro Oncol; 2010 Sep; 12(9):928-40. PubMed ID: 20488958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study.
    Chakraborty S; Filippi CG; Wong T; Ray A; Fralin S; Tsiouris AJ; Praminick B; Demopoulos A; McCrea HJ; Bodhinayake I; Ortiz R; Langer DJ; Boockvar JA
    J Neurooncol; 2016 Jul; 128(3):405-15. PubMed ID: 26945581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naturally Occurring Canine Glioma as a Model for Novel Therapeutics.
    Hubbard ME; Arnold S; Bin Zahid A; McPheeters M; Gerard O'Sullivan M; Tabaran AF; Hunt MA; Pluhar GE
    Cancer Invest; 2018; 36(8):415-423. PubMed ID: 30234401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of magnetic resonance imaging-based preoperative tumor volume with postsurgical survival time in dogs with primary intracranial glioma.
    MacLellan JD; Arnold SA; Dave AC; Hunt MA; Pluhar GE
    J Am Vet Med Assoc; 2018 Jan; 252(1):98-102. PubMed ID: 29244602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral temozolomide in spontaneous canine gliomas: feasibility of a novel therapy using implanted microcylinders.
    Hicks J; Platt S; Stewart G; Senneca C; Holmes S; Kent M; Howerth E; Kaplan J; Kaplan E
    Vet Med Sci; 2019 Feb; 5(1):5-18. PubMed ID: 30394686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
    Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
    J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas.
    Rossmeisl JH; Herpai D; Quigley M; Cecere TE; Robertson JL; D'Agostino RB; Hinckley J; Tatter SB; Dickinson PJ; Debinski W
    Neuro Oncol; 2021 Mar; 23(3):422-434. PubMed ID: 32812637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals.
    Wang W; Sivakumar W; Torres S; Jhaveri N; Vaikari VP; Gong A; Howard A; Golden EB; Louie SG; Schönthal AH; Hofman FM; Chen TC
    Neurosurg Focus; 2015 Mar; 38(3):E8. PubMed ID: 25727230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convection-enhanced Delivery of Therapeutics for Malignant Gliomas.
    Saito R; Tominaga T
    Neurol Med Chir (Tokyo); 2017 Jan; 57(1):8-16. PubMed ID: 27980285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children.
    Anderson RC; Kennedy B; Yanes CL; Garvin J; Needle M; Canoll P; Feldstein NA; Bruce JN
    J Neurosurg Pediatr; 2013 Mar; 11(3):289-95. PubMed ID: 23240851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convection-enhanced delivery of SN-38-loaded polymeric micelles (NK012) enables consistent distribution of SN-38 and is effective against rodent intracranial brain tumor models.
    Zhang R; Saito R; Mano Y; Sumiyoshi A; Kanamori M; Sonoda Y; Kawashima R; Tominaga T
    Drug Deliv; 2016 Oct; 23(8):2780-2786. PubMed ID: 26330269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival times in dogs with presumptive intracranial gliomas treated with oral lomustine: A comparative retrospective study (2008-2017).
    Moirano SJ; Dewey CW; Wright KZ; Cohen PW
    Vet Comp Oncol; 2018 Dec; 16(4):459-466. PubMed ID: 29797768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of linear and volumetric criteria for the determination of therapeutic response in dogs with intracranial gliomas.
    Garcia Mora JK; Robertson J; Hsu FC; Shinn RL; Larson MM; Rylander CG; Whitlow CT; Debinski W; Davalos RV; B Daniel G; Rossmeisl JH
    J Vet Intern Med; 2022 May; 36(3):1066-1074. PubMed ID: 35274379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma.
    Bernal GM; LaRiviere MJ; Mansour N; Pytel P; Cahill KE; Voce DJ; Kang S; Spretz R; Welp U; Noriega SE; Nunez L; Larsen GF; Weichselbaum RR; Yamini B
    Nanomedicine; 2014 Jan; 10(1):149-57. PubMed ID: 23891990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas.
    Yang W; Barth RF; Adams DM; Ciesielski MJ; Fenstermaker RA; Shukla S; Tjarks W; Caligiuri MA
    Cancer Res; 2002 Nov; 62(22):6552-8. PubMed ID: 12438250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.